Discovery and Basic Research
Category: Late Breaking Poster Abstract
Nan Zhao, Ph.D.
WuXi AppTec Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Furong Jiao, M.D. (she/her/hers)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Hongfeng Qian, B.S. (he/him/his)
WuXi AppTec Lab Testing Division
Shanghai, Shanghai, China (People's Republic)
Xuan Dong, M.S. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Li Wang, B.S. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Xiang Ren, M.S. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Jieyu Xiao, M.S. (she/her/hers)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Menglong Wang, B.S. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Yi Chen, B.S.
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Cheng Tang, M.S. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Yi Tao, Pharm.D. (she/her/hers)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Liang Shen, Pharm.D. (he/him/his)
WuXi AppTec (Shanghai) Co., Ltd.
shanghai, Shanghai, China (People's Republic)
Figure 1. Experimental endpoint cornea (left) and sclera (right).
Table 1. Comparison of permeability parameters of gatifloxacin in different dosage forms on cornea and sclera.
Figure 2. The cumulative permeability (Qn ) of gatifloxacin eye drops (left) and gels (right) in cornea or sclera of rabbits.